Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Change in Accured Expenses (2016 - 2017)

Historic Change in Accured Expenses for Fresenius Medical Care AG (FMS) over the last 8 years, with Q4 2017 value amounting to $3.1 million.

  • Fresenius Medical Care AG's Change in Accured Expenses fell 9806.58% to $3.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was $3.1 million, marking a year-over-year decrease of 9677.61%. This contributed to the annual value of $1.3 billion for FY2020, which is 97189.04% up from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Change in Accured Expenses of $3.1 million as of Q4 2017, which was down 9806.58% from $158.2 million recorded in Q4 2016.
  • In the past 5 years, Fresenius Medical Care AG's Change in Accured Expenses registered a high of $301.3 million during Q4 2015, and its lowest value of -$180.3 million during Q1 2014.
  • In the last 5 years, Fresenius Medical Care AG's Change in Accured Expenses had a median value of $86.7 million in 2013 and averaged $61.5 million.
  • Within the past 5 years, the most significant YoY rise in Fresenius Medical Care AG's Change in Accured Expenses was 78558.68% (2013), while the steepest drop was 42623.4% (2013).
  • Fresenius Medical Care AG's Change in Accured Expenses (Quarter) stood at $136.5 million in 2013, then tumbled by 48.89% to $69.8 million in 2014, then soared by 331.85% to $301.3 million in 2015, then tumbled by 47.51% to $158.2 million in 2016, then crashed by 98.07% to $3.1 million in 2017.
  • Its Change in Accured Expenses was $3.1 million in Q4 2017, compared to $158.2 million in Q4 2016 and -$126.3 million in Q3 2016.